Edward J. Gonzalez

910 total citations
9 papers, 661 citations indexed

About

Edward J. Gonzalez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Edward J. Gonzalez has authored 9 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Edward J. Gonzalez's work include Cancer Immunotherapy and Biomarkers (6 papers), Diabetes Treatment and Management (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Edward J. Gonzalez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Diabetes Treatment and Management (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Edward J. Gonzalez collaborates with scholars based in United States, Israel and South Korea. Edward J. Gonzalez's co-authors include Michael J. Davies, Keith D. Kaufman, Juan Camilo Arjona Ferreira, Raanan Berger, Kumudu Pathiraja, Kenneth Emancipator, Marisa Dolled‐Filhart, Peter P. Stein, Juliana C.N. Chan and Russell Scott and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Edward J. Gonzalez

9 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward J. Gonzalez United States	9	393	306	168	136	113	9	661
Q. Shao China	14	207 0.5×	595 1.9×	249 1.5×	49 0.4×	409 3.6×	31	914
Jessie Gu United States	9	187 0.5×	90 0.3×	31 0.2×	192 1.4×	147 1.3×	17	724
Jamie L. Resnik United States	10	134 0.3×	153 0.5×	93 0.6×	90 0.7×	358 3.2×	13	688
Andreas Port Germany	10	92 0.2×	218 0.7×	80 0.5×	25 0.2×	159 1.4×	15	435
H. Tada Japan	8	110 0.3×	220 0.7×	203 1.2×	162 1.2×	135 1.2×	14	839
K. Gary Barnette United States	12	319 0.8×	187 0.6×	39 0.2×	325 2.4×	194 1.7×	31	810
Jochen Ittner Germany	6	109 0.3×	159 0.5×	79 0.5×	18 0.1×	292 2.6×	7	577
Mingzhi Xie China	12	156 0.4×	47 0.2×	66 0.4×	75 0.6×	184 1.6×	28	447
Hidetoshi Satoh Japan	9	68 0.2×	63 0.2×	95 0.6×	57 0.4×	136 1.2×	18	424
Jace Nielsen United States	10	104 0.3×	138 0.5×	65 0.4×	60 0.4×	103 0.9×	19	397

Countries citing papers authored by Edward J. Gonzalez

Since Specialization

Citations

This map shows the geographic impact of Edward J. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Gonzalez more than expected).

Fields of papers citing papers by Edward J. Gonzalez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Gonzalez. The network helps show where Edward J. Gonzalez may publish in the future.

Co-authorship network of co-authors of Edward J. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Gonzalez. A scholar is included among the top collaborators of Edward J. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Gonzalez. Edward J. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Muro, Kei, Yung‐Jue Bang, Veena Shankaran, et al.. (2015). Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.. Journal of Clinical Oncology. 33(3_suppl). 3–3. 92 indexed citations

Nanda, Rita, Laura Q.M. Chow, E. Claire Dees, et al.. (2015). Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer. Cancer Research. 75(9_Supplement). S1–9. 87 indexed citations

Bang, Yung‐Jue, Veena Shankaran, Ravit Geva, et al.. (2015). Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in KEYNOTE-012.. Journal of Clinical Oncology. 33(15_suppl). 4001–4001. 36 indexed citations

Plimack, Elizabeth R., Shilpa Gupta, Joaquim Bellmunt, et al.. (2014). A Phase 1B Study of Pembrolizumab (Pembro; Mk-3475) in Patients (Pts) with Advanced Urothelial Tract Cancer. Annals of Oncology. 25. v1–v1. 41 indexed citations

Chow, Laura Q.M., Barbara Burtness, Jared Weiss, et al.. (2014). A Phase Ib Study of Pembrolizumab (Pembro; Mk-3475) in Patients (Pts) with Human Papiilloma Virus (Hpv)-Positive and Negative Head and Neck Cancer (Hnc). Annals of Oncology. 25. v1–v1. 19 indexed citations

Muro, Kei, Yung‐Jue Bang, Veena Shankaran, et al.. (2014). A Phase 1B Study of Pembrolizumab (Pembro; Mk-3475) in Patients (Pts) with Advanced Gastric Cancer. Annals of Oncology. 25. v1–v1. 48 indexed citations

Ferreira, Juan Camilo Arjona, Dalila B. Corry, Carl Erik Mogensen, et al.. (2013). Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial. American Journal of Kidney Diseases. 61(4). 579–587. 98 indexed citations

Chan, Juliana C.N., Russell Scott, Juan Camilo Arjona Ferreira, et al.. (2008). Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency. Diabetes Obesity and Metabolism. 10(7). 545–555. 190 indexed citations

Xu, Jinyou, Hyun Ok, Edward J. Gonzalez, et al.. (2004). Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(18). 4759–4762. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact